share_log

京新药业(002020.SZ):公司的地达西尼为全球首创的独家品种 多项专利均在保护期内

Zhejiang Jingxin Pharmaceutical (002020.SZ): The company's diadizine is a globally innovative exclusive variety, with multiple patents still under protection.

Gelonghui Finance ·  Dec 18 16:11

Glory Financial, December 18 – Zhejiang Jingxin Pharmaceutical (002020.SZ) stated on the investor interaction platform that the company's dadarizine is a globally pioneering exclusive variety, and currently multiple patents are within the protection period.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment